论文部分内容阅读
目的探讨米非司酮结合介入治疗子宫内膜异位囊肿的临床效果。方法对50例盆腔子宫内膜异位囊肿行经阴道超声引导下囊肿穿刺、抽液并注射无水乙醇(硬化治疗)。术后用药组(30例)开始口服米非司酮2.5mg/(次?d),治疗时间不超过12个月,未用药组(20例)为单行硬化治疗,治疗后追踪观察2年,比较各组的疗效、复发率及副作用发生率。结果联合治疗后的治愈率为73.3%,单纯硬化治疗的治愈率为27.8%,随访跟踪结果联合治疗的复发率26.7%,未服药组的复发率72.2%。结论米非司酮结合介入治疗子宫内膜异位囊肿的临床效果肯定,复发率低。
Objective To investigate the clinical effect of mifepristone combined with interventional treatment of endometriotic cyst. Methods 50 cases of pelvic endometriosis cyst transvaginal ultrasound guided cyst puncture, fluid extraction and injection of ethanol (sclerotherapy). Postoperative medication group (30 cases) started oral mifepristone 2.5mg / (times? D), the treatment time of not more than 12 months, no medication group (20 cases) for the sclerosis treatment, followed up for 2 years after treatment, The curative effect, recurrence rate and incidence of side effects of each group were compared. Results The cure rate after combination therapy was 73.3%. The cure rate of pure sclerotherapy was 27.8%. The follow-up of follow-up combined therapy was 26.7% and that of non-medication group was 72.2%. Conclusion The clinical effect of mifepristone combined with interventional treatment of endometriosis cysts is definite, and the recurrence rate is low.